Terms: = Lung cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
71 results:
1. Association of ccnd1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract] [Full Text] [Related]
2. High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis.
Shen GY; Huang RZ; Yang SB; Shen RQ; Gao JL; Zhang Y
BMC Cancer; 2023 Dec; 23(1):1243. PubMed ID: 38104110
[TBL] [Abstract] [Full Text] [Related]
3. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract] [Full Text] [Related]
4. Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
Bai Y; Zhou L; Zhang C; Guo M; Xia L; Tang Z; Liu Y; Deng S
Oncogene; 2023 Dec; 42(49):3605-3618. PubMed ID: 37864031
[TBL] [Abstract] [Full Text] [Related]
5. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
6. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell lung cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis.
Li F; Lv Q; Wang Y; Zhao S; Guo T; Wang G; Gu C
Am J Clin Oncol; 2023 Sep; 46(9):399-408. PubMed ID: 37390106
[TBL] [Abstract] [Full Text] [Related]
8. Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors.
Ashton E; Arrondeau J; Jouinot A; Boudou-Rouquette P; Hirsch L; Huillard O; Ulmann G; Lupo-Mansuet A; Damotte D; Wislez M; Alifano M; Alexandre J; Goldwasser F
Clin Nutr; 2023 Jun; 42(6):944-953. PubMed ID: 37099986
[TBL] [Abstract] [Full Text] [Related]
9. TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
Kim JY; Jung J; Kim KM; Lee J; Im YH
Cancer Med; 2023 Jun; 12(11):12438-12451. PubMed ID: 37081749
[TBL] [Abstract] [Full Text] [Related]
10. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study.
Zhou T; Zhu S; Xiong Q; Gan J; Wei J; Cai J; Liu A
BMC Cancer; 2023 Apr; 23(1):333. PubMed ID: 37041504
[TBL] [Abstract] [Full Text] [Related]
11. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven lung Tumorigenesis.
Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
[TBL] [Abstract] [Full Text] [Related]
13. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].
Guo Y; Yao ZM; Chen M; Chen CX
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230
[No Abstract] [Full Text] [Related]
14. Hsa_circ_0006692 Promotes lung cancer Progression via miR-205-5p/CDK19 Axis.
Liao J; Chen Z; Luo X; Su Y; Huang T; Xu H; Lin K; Zheng Q; Zhang L; Lin G; Lin X
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627232
[TBL] [Abstract] [Full Text] [Related]
15. Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
Chung CC; Huang TY; Chu HR; De Luca R; Candelotti E; Huang CH; Yang YSH; Incerpi S; Pedersen JZ; Lin CY; Huang HM; Lee SY; Li ZL; ChangOu CA; Li WS; Davis PJ; Lin HY; Whang-Peng J; Wang K
Food Chem Toxicol; 2022 Mar; 161():112850. PubMed ID: 35151786
[TBL] [Abstract] [Full Text] [Related]
16. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
17. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract] [Full Text] [Related]
18. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and prognosis of Non-Small Cell lung cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
19. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
20. USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer.
Zhu M; Zhang H; Lu F; Wang Z; Wu Y; Chen H; Fan X; Yin Z; Liang F
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34533198
[TBL] [Abstract] [Full Text] [Related]
[Next]
